Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature.

Claire BrietMirela Diana IlieEmmanuelle KuhnLuigi MaioneSylvie Brailly-TabardSylvie SalenaveBertrand CariouPhilippe Chanson

Published in: Endocrine (2018)

Treatments used to normalize IGF-I levels in patients with acromegaly could have differential effects on cardiovascular risk factors and metabolic parameters.

Keyphrases

cardiovascular risk factors
cardiovascular disease
metabolic syndrome
growth hormone
electronic health record
combination therapy
machine learning
signaling pathway
artificial intelligence
smoking cessation